職業用医薬品市場:用途別(化学中毒、精神障害、騒音性難聴・振動、皮膚障害、慢性呼吸器疾患、じん肺、筋骨格系障害、がん、その他)、産業別(農林業、建設業、製造業、石油・鉱業、運輸業、その他) - 2027年までの世界の機会分析と産業予測Occupational Medicines Market by Application (Chemical Poisoning, Psychological Disorder, Noise-Induced Hearing Loss & Vibration, Skin Disorder, Chronic Respiratory Disease, Pneumoconiosis, Musculoskeletal Disorder, Cancer, and Others), and Industry (Agriculture & Forestry, Construction, Manufacturing, Petroleum & Mining, Transportation, and Others) - Global Opportunity Analysis and Industry Forecast up to 2027 産業用医薬品市場とは、職場に関連した健康問題に対する医療サービスやソリューションの提供を中心とするヘルスケア産業のセグメントを指す。これには、業務に関連する怪我や病気の予防、診断、治療が含まれる。... もっと見る
サマリー産業用医薬品市場とは、職場に関連した健康問題に対する医療サービスやソリューションの提供を中心とするヘルスケア産業のセグメントを指す。これには、業務に関連する怪我や病気の予防、診断、治療が含まれる。世界中の政府や規制機関が実施する厳しい労働安全衛生規制が、産業用医薬品の需要を押し上げている。雇用主は、適切な医療監視や予防措置を含め、従業員に安全で健康的な職場環境を提供することが求められている。このような規制を遵守するためには、労働災害を評価・管理するために産業用医薬品を使用する必要がある。一方、包括的な産業保健プログラムを実施するためのコストや、産業用医薬品に関する認識や教育の不足が、市場の成長を制限する可能性がある。産業用医薬品市場は、2027年までに年平均成長率6.6%で成長する可能性が高い。産業用医薬品市場:用途別 化学中毒 精神障害 非誘発性難聴・振動 皮膚障害 慢性呼吸器疾患 じん肺 筋骨格系障害 癌 産業別医薬品市場 農業・林業 建設業 製造業 石油・鉱業 運輸 地域別産業用医薬品市場 北米 欧州 アジア太平洋 その他の地域 用途別市場では、職業用医薬品市場は化学中毒、精神障害、非誘発性難聴・振動、皮膚障害、慢性呼吸器疾患、じん肺、筋骨格系障害、がんに区分される。このうち、慢性呼吸器疾患分野が市場で大きなシェアを占めると思われる。これは、世界中で喘息、慢性閉塞性肺疾患(COPD)、珪肺症などの呼吸器疾患が増加しているためである。作業関連の呼吸器疾患は、粉塵、ヒューム、ガスなど、肺を損傷する有害物質を吸い込むことによって引き起こされるいくつかの病気である。職業性肺疾患は呼吸困難に拍車をかけている。 職業用医薬品市場を牽引する主な要因は以下の通り: 労働安全衛生規制:世界中の政府や規制機関は、労働者の安全を確保するために厳しい労働安全衛生規制を実施している。これらの規制を遵守するためには、業務に関連した健康状態を予防・治療するための業務用医薬品の使用が必要となる。 高まる意識:健康な労働力を維持することの重要性について、雇用者の意識が高まっている。産業用医薬品は、従業員の健康を促進し、欠勤を減らし、生産性を向上させる上で重要な役割を果たしている。 職業病の発生率の上昇:呼吸器疾患、筋骨格系損傷、化学物質への暴露など、業務に関連する疾病は増加傾向にある。このため、これらの健康上の懸念に対応できる産業用医薬品に対する需要が生じている。 産業部門の拡大:さまざまな産業が拡大し続けるにつれ、職業上の危険にさらされる労働者の数も増加している。このことが、従業員の健康と安全を確保するための産業用医薬品の必要性をさらに高めている。 技術の進歩:医療技術の進歩により、革新的な診断ツール、治療法、職業病の予防法が開発されている。これが、産業用医薬品市場の成長に寄与している。 産業用医薬品市場の主な主要企業は、Amgen Inc.、AstraZeneca PLC、Bristol-Myers Squibb Company、Eli Lilly and Company、F. Hoffmann-La Roche Ltd.、Johnson & Johnson、Nestlé S.A. (Galderma S.A.)、Novartis AG、Pfizer Inc.、Sanofiである。 産業用医薬品市場には、健康診断、健康診断、予防接種、薬物検査、業務上の怪我や病気の治療など、様々な製品とサービスが含まれる。労働衛生に特化した医薬品と、労働衛生の専門家が提供する広範な医療サービスの両方が含まれる。 市場動向や力学は時間とともに変化する可能性があることに留意することが重要です。したがって、産業用医薬品市場の現状に関する最新情報を得るには、最近の市場調査報告書や業界刊行物を参照し、産業保健分野の関連ステークホルダーに接触することが望ましい。 世界の産業用医薬品市場の阻害要因、機会、課題、市場成長を促進する見込みを包括的に概観。 本レポートは、過去、現在、推定市場規模を数量と金額で示すとともに、詳細な市場セグメンテーションを提供します。 本レポートでは、現在の業界動向と発展、主要企業の競争展望と戦略、製品提供について紹介しています。 また、主要企業のSWOT分析、ポートフォリオ分析、能力分析も掲載しています。 目次1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Application: Market Size & Analysis 5.1. Chemical poisoning 5.2. Psychological disorder 5.3. Non-Induced hearing loss & vibration 5.4. Skin disorder 5.5. Chronic respiratory disease 5.6. Pneumoconiosis 5.7. Musculoskeletal disorder 5.8. Cancer 6. Industry: Market Size & Analysis 6.1. Agriculture & forestry 6.2. Construction 6.3. Manufacturing 6.4. Petroleum & mining 6.5. Transportation 7. Geography: Market Size & Analysis 7.1. Overview 7.2. North America 7.3. Europe 7.4. Asia Pacific 7.5. Rest of the World 8. Competitive Landscape 8.1. Competitor Comparison Analysis 8.2. Market Developments 8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 8.2.2. Product Launches and execution 9. Vendor Profiles 9.1. ELI LILLY AND COMPANY. 9.1.1. Overview 9.1.2. Financial Overview 9.1.3. Product Offerings 9.1.4. Developments 9.1.5. Business Strategy 9.2. ASTRAZENECA PLC, 9.2.1. Overview 9.2.2. Financial Overview 9.2.3. Product Offerings 9.2.4. Developments 9.2.5. Business Strategy 9.3. Novartis AG 9.3.1. Overview 9.3.2. Financial Overview 9.3.3. Product Offerings 9.3.4. Developments 9.3.5. Business Strategy 9.4. JOHNSON & JOHNSON. 9.4.1. Overview 9.4.2. Financial Overview 9.4.3. Product Offerings 9.4.4. Developments 9.4.5. Business Strategy 9.5. BRISTOL-MYERS SQUIBB COMPANY, 9.5.1. Overview 9.5.2. Financial Overview 9.5.3. Product Offerings 9.5.4. Developments 9.5.5. Business Strategy 9.5.6. Business Strategy 9.6. F. HOFFMANN-LA ROCHE LTD 9.6.1. Overview 9.6.2. Financial Overview 9.6.3. Product Offerings 9.6.4. Developments 9.6.5. Business Strategy 9.7. PFIZER IN 9.7.1. Overview 9.7.2. Financial Overview 9.7.3. Product Offerings 9.7.4. Developments 9.7.5. Business Strategy 9.8. Amgen Inc. 9.8.1. Overview 9.8.2. Financial Overview 9.8.3. Product Offerings 9.8.4. Developments 9.8.5. Business Strategy 9.9. SANOFI. 9.9.1. Overview 9.9.2. Financial Overview 9.9.3. Product Offerings 9.9.4. Developments 9.9.5. Business Strategy 9.10. Nestlé S.A 9.10.1. Overview 9.10.2. Financial Overview 9.10.3. Product Offerings 9.10.4. Developments 9.10.5. Business Strategy 10. Analyst Opinion 11. Annexure 11.1. Report Scope 11.2. Market Definitions 11.3. Research Methodology 11.3.1. Data Collation and In-house Estimation 11.3.2. Market Triangulation 11.3.3. Forecasting 11.4. Report Assumptions 11.5. Declarations 11.6. Stakeholders 11.7. Abbreviations 図表リストTABLE 1. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)TABLE 2. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHEMICAL POISONING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PSYCHOLOGICAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR NON-INDUCED HEARING LOSS & VIBRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR SKIN DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 6. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHRONIC RESPIRATORY DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 7. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PNEUMOCONIOSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MUSCULOSKELETAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 9. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 10. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR AGRICULTURE & FORESTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 12. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CONSTRUCTION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 13. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MANUFACTURING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 14. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PETROLEUM & MINING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 15. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 16. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 17. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 18. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 19. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 20. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 21. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 23. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 24. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 25. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 26. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 27. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 28. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 29. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 30. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION 2021-2027 (USD BILLION) TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY 2021-2027 (USD BILLION) TABLE 32. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 33. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 34. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 35. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 36. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 37. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 38. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 39. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 40. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 41. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 42. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 43. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 44. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 46. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 47. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 48. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 49. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 50. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 51. SANOFI: FINANCIALS TABLE 52. SANOFI: PRODUCTS & SERVICES TABLE 53. SANOFI: RECENT DEVELOPMENTS TABLE 54. PFIZER INC: FINANCIALS TABLE 55. PFIZER INC: PRODUCTS & SERVICES TABLE 56. PFIZER INC: RECENT DEVELOPMENTS TABLE 57. ELI LILLY AND COMPANY: FINANCIALS TABLE 58. ELI LILLY AND COMPANY: PRODUCTS & SERVICES TABLE 59. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS TABLE 60. NOVARTIS AG: FINANCIALS TABLE 61. NOVARTIS AG: PRODUCTS & SERVICES TABLE 62. NOVARTIS AG: RECENT DEVELOPMENTS TABLE 63. NESTLÉ S.A. (GALDERMA S.A.): FINANCIALS TABLE 64. NESTLÉ S.A. (GALDERMA S.A.): PRODUCTS & SERVICES TABLE 65. NESTLÉ S.A. (GALDERMA S.A.): RECENT DEVELOPMENTS TABLE 66. ASTRAZENECA PLC: FINANCIALS TABLE 67. ASTRAZENECA PLC: PRODUCTS & SERVICES TABLE 68. ASTRAZENECA PLC: RECENT DEVELOPMENTS TABLE 69. AMGEN INC.: FINANCIALS TABLE 70. AMGEN INC: PRODUCTS & SERVICES TABLE 71. AMGEN INC: RECENT DEVELOPMENTS TABLE 72. F. HOFFMANN-LA ROCHE LTD: FINANCIALS TABLE 73. F. HOFFMANN-LA ROCHE LTD: PRODUCTS & SERVICES TABLE 74. F. HOFFMANN-LA ROCHE LTD: RECENT DEVELOPMENTS TABLE 75. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS TABLE 76. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES TABLE 77. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS TABLE 78. JOHNSON & JOHNSON: FINANCIALS TABLE 79. JOHNSON & JOHNSON: PRODUCTS & SERVICES TABLE 80. JOHNSON & JOHNSON: RECENT DEVELOPMENTS TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS
SummaryThe occupational medicines market refers to the segment of the healthcare industry that focuses on providing medical services and solutions for workplace-related health issues. This includes the prevention, diagnosis, and treatment of work-related injuries and illnesses. Stringent occupational health and safety regulations implemented by governments and regulatory bodies across the world drive the demand for occupational medicines. Employers are required to provide a safe and healthy work environment for their employees, including appropriate medical surveillance and preventive measures. Compliance with these regulations necessitates the use of occupational medicines to assess and manage occupational hazards. On the other hand, the cost of implementing comprehensive occupational health programs and lack of awareness and education on occupational medicines may limit the market growth. Occupational Medicines Market is likely to grow at a rate of 6.6% CAGR by 2027. Table of Contents1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Application: Market Size & Analysis 5.1. Chemical poisoning 5.2. Psychological disorder 5.3. Non-Induced hearing loss & vibration 5.4. Skin disorder 5.5. Chronic respiratory disease 5.6. Pneumoconiosis 5.7. Musculoskeletal disorder 5.8. Cancer 6. Industry: Market Size & Analysis 6.1. Agriculture & forestry 6.2. Construction 6.3. Manufacturing 6.4. Petroleum & mining 6.5. Transportation 7. Geography: Market Size & Analysis 7.1. Overview 7.2. North America 7.3. Europe 7.4. Asia Pacific 7.5. Rest of the World 8. Competitive Landscape 8.1. Competitor Comparison Analysis 8.2. Market Developments 8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 8.2.2. Product Launches and execution 9. Vendor Profiles 9.1. ELI LILLY AND COMPANY. 9.1.1. Overview 9.1.2. Financial Overview 9.1.3. Product Offerings 9.1.4. Developments 9.1.5. Business Strategy 9.2. ASTRAZENECA PLC, 9.2.1. Overview 9.2.2. Financial Overview 9.2.3. Product Offerings 9.2.4. Developments 9.2.5. Business Strategy 9.3. Novartis AG 9.3.1. Overview 9.3.2. Financial Overview 9.3.3. Product Offerings 9.3.4. Developments 9.3.5. Business Strategy 9.4. JOHNSON & JOHNSON. 9.4.1. Overview 9.4.2. Financial Overview 9.4.3. Product Offerings 9.4.4. Developments 9.4.5. Business Strategy 9.5. BRISTOL-MYERS SQUIBB COMPANY, 9.5.1. Overview 9.5.2. Financial Overview 9.5.3. Product Offerings 9.5.4. Developments 9.5.5. Business Strategy 9.5.6. Business Strategy 9.6. F. HOFFMANN-LA ROCHE LTD 9.6.1. Overview 9.6.2. Financial Overview 9.6.3. Product Offerings 9.6.4. Developments 9.6.5. Business Strategy 9.7. PFIZER IN 9.7.1. Overview 9.7.2. Financial Overview 9.7.3. Product Offerings 9.7.4. Developments 9.7.5. Business Strategy 9.8. Amgen Inc. 9.8.1. Overview 9.8.2. Financial Overview 9.8.3. Product Offerings 9.8.4. Developments 9.8.5. Business Strategy 9.9. SANOFI. 9.9.1. Overview 9.9.2. Financial Overview 9.9.3. Product Offerings 9.9.4. Developments 9.9.5. Business Strategy 9.10. Nestlé S.A 9.10.1. Overview 9.10.2. Financial Overview 9.10.3. Product Offerings 9.10.4. Developments 9.10.5. Business Strategy 10. Analyst Opinion 11. Annexure 11.1. Report Scope 11.2. Market Definitions 11.3. Research Methodology 11.3.1. Data Collation and In-house Estimation 11.3.2. Market Triangulation 11.3.3. Forecasting 11.4. Report Assumptions 11.5. Declarations 11.6. Stakeholders 11.7. Abbreviations List of Tables/GraphsTABLE 1. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)TABLE 2. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHEMICAL POISONING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PSYCHOLOGICAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR NON-INDUCED HEARING LOSS & VIBRATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR SKIN DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 6. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CHRONIC RESPIRATORY DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 7. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PNEUMOCONIOSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MUSCULOSKELETAL DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 9. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CANCER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 10. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 11. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR AGRICULTURE & FORESTRY, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 12. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR CONSTRUCTION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 13. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR MANUFACTURING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 14. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR PETROLEUM & MINING, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 15. GLOBAL OCCUPATIONAL MEDICINES MARKET VALUE FOR TRANSPORTATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 16. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 17. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 18. NORTH AMERICA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 19. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 20. U.S OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 21. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 22. CANADA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 23. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 24. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 25. EUROPE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 26. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 27. GERMANY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 28. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 29. U.K OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 30. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION 2021-2027 (USD BILLION) TABLE 31. FRANCE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY 2021-2027 (USD BILLION) TABLE 32. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 33. ITALY OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 34. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 35. SPAIN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 36. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 37. ROE OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 38. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 39. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 40. ASIA PACIFC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 41. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 42. CHINA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 43. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 44. INDIA OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 45. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 46. JAPAN OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 47. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 48. REST OF APAC OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 49. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 50. REST OF WORLD OCCUPATIONAL MEDICINES MARKET VALUE, BY INDUSTRY, 2021-2027 (USD BILLION) TABLE 51. SANOFI: FINANCIALS TABLE 52. SANOFI: PRODUCTS & SERVICES TABLE 53. SANOFI: RECENT DEVELOPMENTS TABLE 54. PFIZER INC: FINANCIALS TABLE 55. PFIZER INC: PRODUCTS & SERVICES TABLE 56. PFIZER INC: RECENT DEVELOPMENTS TABLE 57. ELI LILLY AND COMPANY: FINANCIALS TABLE 58. ELI LILLY AND COMPANY: PRODUCTS & SERVICES TABLE 59. ELI LILLY AND COMPANY: RECENT DEVELOPMENTS TABLE 60. NOVARTIS AG: FINANCIALS TABLE 61. NOVARTIS AG: PRODUCTS & SERVICES TABLE 62. NOVARTIS AG: RECENT DEVELOPMENTS TABLE 63. NESTLÉ S.A. (GALDERMA S.A.): FINANCIALS TABLE 64. NESTLÉ S.A. (GALDERMA S.A.): PRODUCTS & SERVICES TABLE 65. NESTLÉ S.A. (GALDERMA S.A.): RECENT DEVELOPMENTS TABLE 66. ASTRAZENECA PLC: FINANCIALS TABLE 67. ASTRAZENECA PLC: PRODUCTS & SERVICES TABLE 68. ASTRAZENECA PLC: RECENT DEVELOPMENTS TABLE 69. AMGEN INC.: FINANCIALS TABLE 70. AMGEN INC: PRODUCTS & SERVICES TABLE 71. AMGEN INC: RECENT DEVELOPMENTS TABLE 72. F. HOFFMANN-LA ROCHE LTD: FINANCIALS TABLE 73. F. HOFFMANN-LA ROCHE LTD: PRODUCTS & SERVICES TABLE 74. F. HOFFMANN-LA ROCHE LTD: RECENT DEVELOPMENTS TABLE 75. BRISTOL-MYERS SQUIBB COMPANY: FINANCIALS TABLE 76. BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS & SERVICES TABLE 77. BRISTOL-MYERS SQUIBB COMPANY: RECENT DEVELOPMENTS TABLE 78. JOHNSON & JOHNSON: FINANCIALS TABLE 79. JOHNSON & JOHNSON: PRODUCTS & SERVICES TABLE 80. JOHNSON & JOHNSON: RECENT DEVELOPMENTS TABLE 81. TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS TABLE 82. TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES TABLE 83. TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IHR Insights社の医療分野での最新刊レポート
本レポートと同じKEY WORD(application chemical)の最新刊レポート
よくあるご質問IHR Insights社はどのような調査会社ですか?IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |